A1C INSIGHTS: CGM + AskSally AI

A1C Insights is listed on Apple’s App Store as a consumer health app from developer A1C PTE. LTD., and the project markets an AI metabolic agent called “Sally” alongside a conversational feature named AskSally. (apps.apple.com) (asksally.xyz) The company sells subscription bundles that include physical continuous‑glucose‑monitor sensors packaged with app access — the one‑month plan ships two sensors for about 28 days of tracking and the three‑month plan ships six sensors for about 84 days — and those paid plans advertise “unlimited conversations” with Sally. (shop.a1c.io 1) (shop.a1c.io 2) A continuous‑glucose monitor is a small wearable sensor that samples glucose in the fluid under the skin many times per hour and delivers a live stream of sugar readings; A1C Insights says it ingests that stream and pairs it with other phone data (sleep, activity, environment) to show day‑to‑day patterns and a summarized “body battery” like score. (my.clevelandclinic.org) (apps.apple.com) AskSally is presented as a conversational AI trained on metabolic and preventive‑health material that users can chat with for personalized suggestions and explanations, and the official site and shop pages emphasize real‑time guidance tied to the sensor data. (asksally.xyz) (shop.a1c.io) The Sally/A1C brand also has a crypto token and Web3 presence: the A1C (Sally) token is listed on market trackers such as CoinGecko and appears on Base‑chain trading pools, which the project uses in its marketing and community channels. (coingecko.com) (geckoterminal.com)